RESEARCH BASE
Search 3,721 documents across 34 fields — every claim tier-rated by evidence
3,633 are the core, quality-scored corpus (34 lettered sections — see How We Work); the remaining 88 are cross-corpus synthesis documents (68 InterDocs, 12 Connections, 8 Theories) also indexed here.
3,721 results for "N" — page 45 of 187
Z_3_01 — Genetics of Brain Development — ASPM, Microcephalin, HAR1
The human brain is approximately three times larger than expected for a primate of our body size, with a vastly expanded cerebral cortex containing ~86 billion neurons. Identifying the genetic basis for this extraordinar
Z_2_15 — Future of Genomics and Personalized Medicine
Genomics is undergoing a transition from research tool to clinical infrastructure. The cost of whole-genome sequencing (WGS) has plummeted from $2.7 billion (Human Genome Project, 1990–2003) to ~$200 per genome (Illumina
Z_2_13 — Pharmacogenomics and Personalized Medicine
Pharmacogenomics — the study of how genetic variation influences drug response — is among the most clinically actionable applications of human genetics. Adverse drug reactions (ADRs) are the 4th–6th leading cause of deat
Z_2_19 — Senolytics & Geroscience: Targeting Cellular Senescence in Aging
Cellular senescence — the irreversible arrest of cell division first described by Leonard Hayflick and Paul Moorhead (1961, Experimental Cell Research) — has emerged as a central mechanism of aging and age-related diseas
Z_2_10 — Genetics of Aging and Progeria
Aging — the progressive decline in physiological function leading to increased vulnerability to disease and death — has a substantial genetic component: twin studies estimate heritability of human lifespan at ~25–30% (He
Z_2_03 — Pharmacogenomics & Ethnobotanical Genetics
Pharmacogenomics — the study of how genetic variation affects drug response — has revealed that enzymes governing drug metabolism, particularly the cytochrome P450 (CYP) superfamily, show extraordinary population-specifi
Z_2_08 — Prion Genetics and Misfolded Proteins
Prions are infectious agents composed entirely of misfolded protein — the only known pathogen that contains no nucleic acid (no DNA, no RNA). The protein-only hypothesis (Stanley Prusiner, 1982 — Nobel Prize 1997) states
Z_2_17 — Prion Biology: Self-Propagating Protein Misfolding and Transmissible Encephalopathies
Prions — proteinaceous infectious particles lacking nucleic acid — represent a paradigm-shattering departure from the central dogma that biological information flows from DNA to RNA to protein. The protein-only hypothesi
Z_2_18 — Pharmacogenomics and Precision Medicine
Pharmacogenomics — the study of how genetic variation affects individual responses to drugs — aims to replace the "one-size-fits-all" prescribing model with genotype-guided therapy, selecting the right drug at the right
Z_2_12 — Genetics of Pain Perception
Pain perception — the subjective experience triggered by actual or potential tissue damage — varies enormously across individuals, with genetic factors accounting for 25–50% of the variance in pain sensitivity (twin stud
Z_2_21 — Epigenetic Aging Clocks
Epigenetic aging clocks are mathematical models that use patterns of DNA methylation at specific CpG dinucleotides across the genome to estimate an individual's biological age with remarkable accuracy — typically within
Z_2_09 — Mitochondrial Genetics and Diseases
Human mitochondrial DNA (mtDNA) is a 16,569-bp circular genome encoding 37 genes: 13 proteins (all subunits of the oxidative phosphorylation/OXPHOS complexes I, III, IV, and V), 22 transfer RNAs, and 2 ribosomal RNAs. Un
Z_2_04 — Genetic Disorders and Inborn Errors of Metabolism
Genetic disorders — diseases caused by mutations in single genes (monogenic) or chromosomal abnormalities — affect ~3–5% of live births and collectively represent thousands of distinct conditions catalogued in the Online
Z_2_06 — Nutrigenomics and Diet-Gene Interactions
Nutrigenomics — the study of how genetic variation influences nutritional requirements, dietary responses, and disease susceptibility — and its complement nutrigenetics (how diet influences gene expression) represent a r
Z_2_14 — Genetics of Longevity and Blue Zones
The genetics of human longevity — why some individuals live past 100 while most do not — is a field where heritability is modest, effect sizes are small, and environmental factors dominate, yet several genetic pathways h
Z_2_11 — Genetics of Immunity and MHC Diversity
The major histocompatibility complex (MHC) — known as the human leukocyte antigen (HLA) system in humans — is the most polymorphic gene region in the human genome, encoding cell-surface glycoproteins essential for adapti
Z_2_02 — Telomere Biology & Genetics of Aging
Telomeres — repetitive DNA sequences (TTAGGG)ₙ capping the ends of linear chromosomes — serve as protective buffers against chromosome degradation, end-to-end fusion, and the progressive DNA loss inherent in the end-repl
Z_2_16 — Cancer Genomics & Precision Oncology
Cancer genomics — the comprehensive analysis of the genetic alterations that drive cancer initiation, progression, and resistance to therapy — has transformed oncology from a tissue-of-origin classification system into a
Z_2_07 — Genetics of Disease Resistance
Infectious disease has been the most powerful selective force shaping the human genome, leaving signatures across thousands of loci. The best-understood example is sickle cell disease (HbS, Glu6Val in HBB): heterozygous
Z_2_05 — Gene Therapy: History and Progress
Gene therapy — the introduction, alteration, or replacement of genetic material within a patient's cells to treat or cure disease — has evolved from a speculative concept to an approved clinical reality over five decades
BROWSE BY SECTION — 3,721 documents across 34 fields